G Hale
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation 78
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments 22
- Immunology top 0.1%
- T-cell and B-cell Immunology 41
- Immune Cell Function and Interaction 26
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 26
- Pathology and Forensic Medicine top 0.2%
-
- Monoclonal and Polyclonal Antibodies Research 72
-
- Glycosylation and Glycoproteins Research 37
- Protein purification and stability 21
- Co-authors
- Herman WaldmannMartin J.S. DyerRichard N. PerhamJohn D. IsaacsAlasdair ColesMike ClarkStephen CobboldMark Wing
- Cited by
- HematologyTransplantationImmunology
- Partner nations
- United KingdomUnited StatesSouth Sudan
In The Last Decade
G Hale
262 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Hematology 4.7k
- Transplantation 1.1k
- Immunology 6.7k
- Genetics 2.5k
- Pathology and Forensic Medicine 3.2k
Countries citing papers authored by G Hale
This map shows the geographic impact of G Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Hale more than expected).
Fields of papers citing papers by G Hale
This network shows the impact of papers produced by G Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Hale. The network helps show where G Hale may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G Hale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 19 | |
| 3 | 2024 | 6 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 65 | |
| 6 | Neutralising TNF activity leads to remission in refractory posterior non-infectious uveitis | 2004 | 1 |
| 7 | Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. | 2003 | 5 |
| 8 | Anti-TNFalpha Therapy in Patients with Posterior Segment Intraocular Inflammation Refractory to Conventional Immunosuppressants | 2003 | 1 |
| 9 | Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. | 2001 | 4 |
| 10 | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). | 2001 | 4 |
| 11 | Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma. | 1999 | 5 |
| 12 | 1999 | 6 | |
| 13 | Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia. | 1996 | 2 |
| 14 | Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion. | 1996 | 6 |
| 15 | 1994 | 68 | |
| 16 | ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES | 1993 | 3 |
| 17 | Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion. | 1993 | 8 |
| 18 | BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS | 1988 | 1 |
| 19 | EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY | 1988 | 1 |
| 20 | INVITRO TREATMENT OF MARROW WITH ATCG OR CAMPATH-1 FOR PROPHYLAXIS OF GVHD - RESULTS OF THE AG-KMT MUNCHEN | 1985 | 2 |
About G Hale
G Hale is a scholar working on Hematology, Transplantation, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 267 papers that have together received 15.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (78 papers), Monoclonal and Polyclonal Antibodies Research (72 papers), T-cell and B-cell Immunology (41 papers), Glycosylation and Glycoproteins Research (37 papers), Chronic Lymphocytic Leukemia Research (26 papers), Immune Cell Function and Interaction (26 papers), Renal Transplantation Outcomes and Treatments (22 papers) and Protein purification and stability (21 papers). The work is most often cited by research in Hematology (4.7k citations), Transplantation (1.1k citations), Immunology (6.7k citations), Genetics (2.5k citations) and Pathology and Forensic Medicine (3.2k citations). G Hale has collaborated with scholars based in United Kingdom, United States and South Sudan. Frequent co-authors include Herman Waldmann, Martin J.S. Dyer, Richard N. Perham, John D. Isaacs, Alasdair Coles, Mike Clark, Stephen Cobbold, Mark Wing, Alastair Compston and Helen Tighe. Their work appears in journals such as Blood, British Journal of Haematology, Transplantation, Bone Marrow Transplantation and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.